Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study

PURPOSE: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is currently the major threat for immunocompromised individuals. The course of COVID-19 in lung transplant recipients in the Omicron era remains unknown. The aim of the study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Kneidinger, Nikolaus, Hecker, Matthias, Bessa, Vasiliki, Hettich, Ina, Wald, Alexandra, Wege, Sabine, Nolde, Anna-Barbara, Oldigs, Maike, Syunyaeva, Zulfiya, Wilkens, Heinrike, Gottlieb, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461411/
https://www.ncbi.nlm.nih.gov/pubmed/36083405
http://dx.doi.org/10.1007/s15010-022-01914-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461411/
https://www.ncbi.nlm.nih.gov/pubmed/36083405
http://dx.doi.org/10.1007/s15010-022-01914-8

Ejemplares similares